S. Wei

Oncology · Cancer Discovery · 2015–2018

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Wei trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll
  2. L. Walker
  3. S. Topalian
  4. Kai Wang
  5. Sean Bendall
  6. J. Wolchok
  7. Erin F. Simonds
  8. James P. Allison
  9. Daniel C. Koboldt
  10. E. Wherry

Papers from S. Wei's perspective

Ordered by how strongly the researchers S. Wei trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  2. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  3. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
  4. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
  5. Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates (Journal of Clinical Oncology)
  6. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (Genome Research)
  7. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
  8. COMPREHENSIVE CLASSIFICATION OF RETINAL BIPOLAR NEURONS BY SINGLE-CELL TRANSCRIPTOMICS
  9. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
  10. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis

Their papers